Business Description
Usana Health Sciences Inc
NAICS : 311999
SIC : 2021
ISIN : US90328M1071
Compare
Compare
Traded in other countries / regions
USNA.USAUSJ.Germany IPO Date
2015-11-17Description
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 44.56 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 613.44 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 7.77 | |||||
| Beneish M-Score | -2.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.6 | |||||
| 3-Year EBITDA Growth Rate | -3.9 | |||||
| 3-Year EPS without NRI Growth Rate | -6.6 | |||||
| 3-Year FCF Growth Rate | 0.1 | |||||
| 3-Year Book Growth Rate | 11.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 12 | |||||
| Future 3-5Y Total Revenue Growth Rate | -5.42 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.84 | |||||
| 9-Day RSI | 41.14 | |||||
| 14-Day RSI | 36.89 | |||||
| 6-1 Month Momentum % | -26.32 | |||||
| 12-1 Month Momentum % | -16.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.47 | |||||
| Quick Ratio | 2.94 | |||||
| Cash Ratio | 2.73 | |||||
| Days Inventory | 129.56 | |||||
| Days Payable | 20.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 3.9 | |||||
| Shareholder Yield % | 0.15 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.51 | |||||
| Operating Margin % | 9.85 | |||||
| Net Margin % | 6.45 | |||||
| FCF Margin % | 8.08 | |||||
| ROE % | 13.35 | |||||
| ROA % | 10.1 | |||||
| ROIC % | 17.09 | |||||
| ROC (Joel Greenblatt) % | 102.76 | |||||
| ROCE % | 21.15 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.22 | |||||
| Forward PE Ratio | 15.04 | |||||
| PE Ratio without NRI | 15.22 | |||||
| Shiller PE Ratio | 9.65 | |||||
| Price-to-Owner-Earnings | 15.51 | |||||
| PEG Ratio | 4.91 | |||||
| PS Ratio | 0.98 | |||||
| PB Ratio | 1.91 | |||||
| Price-to-Tangible-Book | 2.1 | |||||
| Price-to-Free-Cash-Flow | 12.17 | |||||
| Price-to-Operating-Cash-Flow | 10.68 | |||||
| EV-to-EBIT | 6.14 | |||||
| EV-to-EBITDA | 5.07 | |||||
| EV-to-Revenue | 0.66 | |||||
| EV-to-Forward-Revenue | 0.69 | |||||
| EV-to-FCF | 8.28 | |||||
| Price-to-Projected-FCF | 0.63 | |||||
| Price-to-DCF (Earnings Based) | 1.06 | |||||
| Price-to-DCF (FCF Based) | 0.85 | |||||
| Price-to-Median-PS-Value | 0.6 | |||||
| Price-to-Graham-Number | 1.19 | |||||
| Price-to-Net-Current-Asset-Value | 3.43 | |||||
| Price-to-Net-Cash | 5.05 | |||||
| Earnings Yield (Greenblatt) % | 16.28 | |||||
| FCF Yield % | 8.43 | |||||
| Forward Rate of Return (Yacktman) % | 7.78 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Usana Health Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 866.945 | ||
| EPS (TTM) (€) | 2.884 | ||
| Beta | 0.35 | ||
| Volatility % | 28.69 | ||
| 14-Day RSI | 36.89 | ||
| 14-Day ATR (€) | 0.903323 | ||
| 20-Day SMA (€) | 42.17 | ||
| 12-1 Month Momentum % | -16.83 | ||
| 52-Week Range (€) | 40.8 - 62 | ||
| Shares Outstanding (Mil) | 19.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Usana Health Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Usana Health Sciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Usana Health Sciences Inc Frequently Asked Questions
What is Usana Health Sciences Inc(STU:USJ)'s stock price today?
The current price of STU:USJ is €42.20. The 52 week high of STU:USJ is €62.00 and 52 week low is €40.80.
When is next earnings date of Usana Health Sciences Inc(STU:USJ)?
The next earnings date of Usana Health Sciences Inc(STU:USJ) is 2024-02-08 Est..
Does Usana Health Sciences Inc(STU:USJ) pay dividends? If so, how much?
Usana Health Sciences Inc(STU:USJ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers